
A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia
Keywords: allo-HSCT; allogeneic hematopoietic stem cell transplantation; AML; acute myeloid leukemia; APC; allophycocyanin; CML; chronic myeloid leukemia; CFDA; 5,6-carboxyfluorescein diacetate succinimidyl ester; DLT; donor lymphocyte transfusions; ELISPOT; enzyme